Clinical Trials Logo

Filter by:
NCT ID: NCT06236828 Completed - Stroke Clinical Trials

The MRI-based Evaluation of Safety and Efficacy of EVT and SMT: A Retrospective, Multicenter Study

Start date: January 31, 2023
Phase:
Study type: Observational

Acute Basilar Artery Occlusion (ABAO), a condition with a high risk of mortality or disability (up to 80%). The safety and efficacy of endovascular thrombectomy (EVT) in ABAO remains uncertain due to inconsistent evidence from random controlled trials (RCTs). Recent studies have explored the use of MRI in ABAO, this study aims to assess the efficacy and safety of EVT and standard medical therapy (SMT) in the treatment of ABAO within 24 hours of onset. It also aims to explore the feasibility and prognostic value of MRI-based assessment of ABAO infarction using AI image analysis software.

NCT ID: NCT06234241 Completed - Heart Chambers Clinical Trials

Normal Values of Cardiac Measurements by Echocardiography in Chinese Based on Artificial Intelligence

Start date: June 1, 2023
Phase:
Study type: Observational

Establish echocardiographic normal reference values of Chinese Han adults based on artificial intelligence.

NCT ID: NCT06233916 Completed - Mass Balance Study Clinical Trials

Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male Subjects

Start date: December 8, 2023
Phase: Phase 1
Study type: Interventional

- To quantitatively analyze the total radioactivity (TRA) in excrement after a single oral dose of [14C] D-1553 in healthy subjects, and obtain radioactivity recovery and primary excretion pathways in humans; - To obtain radioactive metabolite profiles of human plasma, urine and feces , identify major metabolites of D-1553 and determine the major metabolic pathways and elimination pathways; - To quantitatively analyze the TRA in whole blood and plasma and obtain PK parameters of plasma TRA and investigate whole blood/plasma ratio for TRA.

NCT ID: NCT06233396 Completed - Clinical trials for the Diffenence of Different Detector Row 4DCT,Especially in Artifects,Radiation Dose and Target Volume

Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer

Start date: March 1, 2023
Phase:
Study type: Observational

Currently there are very few studies using wide-body detectors for 4DCT to determine lung tumor volume and comparing them with conventional detector 4DCT images, and no prospective clinical trials comparing 4DCT images from different width detectors have been queried, therefore, in this study, we will prospectively explore in a body model and patients: 1) the degree of artifacts, tumor volume, and radiation dose of the 4DCT scans performed by different width detectors. differences, and scanning radiation dose. (ii) Whether there are differences in different tumor ITV outlining modalities on 4DCT with different detector widths.

NCT ID: NCT06232967 Completed - Clinical trials for Non-small-cell Lung Cancer (NSCLC)

PPIO-006 Primary Tumor Resection for IVa NSCLC

Start date: April 1, 2023
Phase:
Study type: Observational

The goal of this mutli-center observational study is toinvestigate the impact of primary tumor resection (PTR) on the long-term survival of patients with non-small-cell lung cancer (NSCLC) and dry pleural dissemination (DPD). The main question it aims to answer is: whether primary tumor resection improve long-term survival of NSCLC patients with dry pleural dissemination.

NCT ID: NCT06232785 Completed - Clinical trials for Postoperative Nausea and Vomiting

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

Start date: February 1, 2022
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare the analgesic effect of sufentanil and ibuprofen and the incidence of vomiting, and to choose better postoperative analgesic drugs for motion sickness patients.in describe participant population. The main questions it aims to answer are: - Whether this anesthesia method can meet the analgesic needs of gynecological laparoscopic surgery. - Whether this anesthesia method can reduce the incidence of nausea and vomiting in patients with motion sickness after gynecological laparoscopic surgery. Participants will use target-controlled infusion anesthesia combined with 0.8g ibuprofen injection. Researchers will compare with use of target-controlled infusion combined with sufentanil to see if the incidence of nausea and vomiting is higher.

NCT ID: NCT06232759 Completed - Clinical trials for Hepatocellular Carcinoma

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

Start date: April 1, 2022
Phase: Phase 2
Study type: Interventional

Most hepatocellular carcinoma (HCC) are found in the intermediate or advanced stage. The patients lose the opportunity of curative surgical resection. In clinical practice, unresectable HCC is often encountered with large tumor lesions and insufficient remaining liver volume. It is expected that the benefit of direct surgical resection will not exceed that of non-surgical treatment if the tumor is limited in scope but with unclear boundaries, surrounding small foci, or adjacent to important vascular structures, or combined with secondary or higher portal vein tumor thrombus. These patients account for a significant proportion of unresectable HCC, but have the potential for surgical resection. If the investigators can make full use of the existing HCC treatment, the patients hope to obtain radical surgical resection opportunities and better long-term survival after tumor shrinkage and tumor necrosis boundary becomes clear. Transcatheter arterial chemoembolization (TACE) has been the standard arterial treatment for advanced HCC. Tyrosine kinase Inhibitor is the first-line treatment for hepatocellular carcinoma. Tislelizumab is an immune checkpoint inhibitor and a first-line treatment for HCC. This study investigated the efficacy and safety of TACE combined with Tyrosine Kinase Inhibitors and tislelizumab in the treatment of unresectable HCC.

NCT ID: NCT06231277 Completed - Solid Tumours Clinical Trials

Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors

BH002-?-101
Start date: April 26, 2022
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to about in Patients With Advanced Solid Tumors. The main question[s] it aims to answer are: - question 1:Evaluating the tolerability of BH002 injection in Chinese patients with advanced solid tumors - question 2:Obtain the pharmacokinetic (PK) characteristics of BH002 injection in Chinese patients with advanced solid tumors

NCT ID: NCT06230133 Completed - Clinical trials for Posttraumatic Stress Symptom

Feasibility and the Effects of Mindfulness-Based Stress Reduction (MBSR) on College Students

Start date: February 25, 2023
Phase: N/A
Study type: Interventional

The goal of this retrospective control study is to learn about the effects of Mindfulness Based Stress Reduction (MBSR) intervention in military medical students' resilience, post-traumatic stress disorder symptoms (PTSD) and posttruamatic growth (PTG) etc. The main questions are aims to answer: 1. Would MBSR intervention improve psychological resilience, mindful attention awareness, satisfaction with life, and post-traumatic growth in military medical students? 2. Would MBSR intervention reduce anxiety, depression, and PTSD symptoms in military medical students? 3. Would the effects of MBSR intervention persist for at least one month in military medical students? Participants in the intervention group will complete 8-week of MBSR training while those in the control group will not. Researchers will compare resilience, mindful attention awareness, satisfaction with life, and post-traumatic growth, etc. between the two groups.

NCT ID: NCT06228131 Completed - Early Pregnancy Clinical Trials

Detection of hCG in Early Pregnancy Clinical Samples

Start date: August 1, 2023
Phase:
Study type: Observational [Patient Registry]

To evaluate the detection of hCG in the early pregnancy urine samples by Human chorionic gonadotropin (HCG) test system.